WHO vaccine-preventable diseases: monitoring system. 2013 global summary

Last updated 20-Octl-2013 (data as of 16-Oct-2013)
Next overall update June 2014
EPI mother and child logo         
Select a country

Development status: Least developed GNI / capita (US$): 8401 Infant (under 12 months) mortality rate: 372
GDP / capita (US$): 1'8831 Child (under 5 years) mortality rate: 462

Population data in thousands3

  2012  2011  2010  2009  2008  2000  1990  1980 
Total population 154'695  152'862  151'125  149'503  147'970  132'383  107'386  82'498 
Births 3'150  3'161  3'174  3'193  3'219  3'576  3'768  3'560 
Surviving infants 3'045  3'049  3'055  3'065  3'083  3'353  3'406  3'098 
Pop. less than 5 years 15'074  15'118  15'309  15'474  15'723  16'731  16'553  14'325 
Pop. less than 15 years 47'197  47'475  47'852  48'103  48'406  48'951  45'160  36'594 
Female 15-49 years 43'170  42'427  41'634  40'848  40'034  32'645  24'027  17'546 

Number of reported case

(Click for retrospective incidence data for Bangladesh)
Diphtheria 16  11  27  23  43  21  711  1'559 
Japanese encephalitis 52  103  15  15  702 
Measles 1'986  5'625  788  718  2'660  5'098  1'705  11'077 
Mumps
Pertussis 13  44  17  16  33  252  4'879  12'436 
Polio* 198  374  65 
Rubella 3'245  5'631  12'963  13'076  5'526 
Rubella (CRS)
Tetanus (neonatal) 109  98  117  121  152  376  740  1'068 
Tetanus (total) 614  644  710  791  943  1'155  2'511  2'855 
Yellow fever
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV);"
"it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Bangladesh)
Vaccine year result method % card seen                                                
BCG 2010  98  DHS   66.7  99  99  99  99  98  95  91 
DTP1 2010  98  DHS   66.7  99  99  99  99  98  88 
DTP3 2010  93  DHS   66.7  90  90  89  87  87  68  69 
HepB_BD         
HepB3 2010  93  DHS   66.7  90  90  89  87  87 
Hib3 2010  93  DHS   66.7  90  90  95  87 
JapEnc         
MCV 2010  88  DHS   66.7  89  86  89  88  85  61  82 
MCV2          22 
PCV1         
PCV3         
Pol3 2010  93  DHS   66.7  95  95  94  94  93  68  69 
Rota1         
Rota_last         
Rubella1          17 
TT2plus 2010  42  DHS   66.7  96  96  95  95  93  89  73 
PAB         
VAD1          92  85  93  82  89  68 
YFV         
  ° indicates that more than 1 survey occurred that year

  Next update: July 2014

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Bangladesh)
BCG 95  95  94  94  90  95  86 
DTP1 99  99  98  97  95  88  86 
DTP3 96  96  95  96  95  82  69 
HepB3 96  96  95  96  95 
Hib3 96  96  95  96 
MCV 96  96  94  98  96  72  65 
PAB 94  94  93  93  91  89  70 
PCV3
Pol3 96  96  95  96  95  81  69 
Rota_last

Number of districts in the country 64  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
100 
   
/
|
|
\
Greater or equal to 90% 91
From 80 to 89% 9
From 50 to 79% 0
Less than 50% 0
Proportion of districts
not reporting DTP3 coverage
0
 

Immunization Schedule (2012 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG birth; Yes
DTwPHibHepB 6, 10, 14 weeks; Yes
MR 38 weeks; 15 years Yes dose at Y15 is for women only
Measles 15 Months; Yes
OPV 6, 10, 14, 38 weeks; Yes
TT 15 years; +1, +6 months; +1, +1 year; Yes
VitaminA 6-59 months; Yes

Immunizaton indicators

Indicator Expected answer 2012  2011  2010  2009  2008  2007  2006 

Planning and management

Multi-year plan (MYP) for immunization Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 
What years does the MYP cover? number 2011-2016  2011-2016  2011-2016  2008-2010  2008-2010  2008-2010  2008-2012 
Nº of districts with microplans that include activities to raise immunization coverage number 70  64  64  64  64  64  64 

National Immunization Advisory Mechanism

Does the country have a standing technical advisory group on immunization? Yes/No/NR Yes  Yes  Yes         

System performance

Total number of districts in country number 64  64  64  64  64  64  64 
Nº districts with DTP3 coverage >=80% number 64  51  51  51  51  53  51 
% of districts with DTP3 coverage >=80% From 0 to 100% 100  80  80  80  80  83  80 
Nº districts with measles (MCV1) coverage >=95% number 54  26  28  35  35     
% of districts with MCV1 coverage >=95% From 0 to 100% 84  41  44  55  55     

Safety

Monitoring of Adverse Events Following Immunization (AEFI)? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 
Does your country have a vaccine adverse events review committee? Yes/No/NR/ND Yes  Yes  Yes         

Finance

Percentage of routine vaccines funded by Government From 0 to 100% 37  30  29  30  85  60  63 

Maternal and neonatal tetanus (NT) elimination

NT eliminated Yes/No Yes  Yes  Yes  Yes  Yes  No  No 

Sources

Unless otherwise specified, data provided by Member States through WHO-UNICEF Joint Reporting Form and WHO Regional offices.
 1  "The 2013 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2012, data for 2011
 3  "United Nations, Population Division. The World Population Prospects - the 2012 revision". New York, 2013.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.